Iodinated contrast media

ADVERTISEMENT

Identification

Molecular formula
C10H8I3NO3
CAS Number
132-94-9
IUPAC Name
2-(3-acetamido-2,4,6-triiodo-phenyl)acetic acid
Molecular Weight
541.99g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
2.3000g/cm3
Synonyms
BRN 2753527
Interesting facts

Interesting Facts about 2-(3-acetamido-2,4,6-triiodo-phenyl)acetic Acid

2-(3-acetamido-2,4,6-triiodo-phenyl)acetic acid, commonly referred to in its abbreviated form, is a fascinating compound noteworthy for its unique combination of iodine substitutions and functional groups. Here are some interesting insights:

  • Structural Complexity: This compound features a phenyl ring that is heavily substituted with three iodine atoms and an acetamido group, which contributes to its intriguing chemical reactivity and properties.
  • Medical Relevance: Compounds with iodine atoms are often studied for their applications in medical imaging, particularly in radiology and nuclear medicine, due to the radioisotopes of iodine used for diagnostics.
  • Potential Anti-Cancer Agent: The molecular structure suggests potential biological activity, making it a promising candidate for research in anti-cancer therapies as compounds with similar structures have shown to interfere with cancer cell proliferation.
  • Halogen Chemistry: The presence of iodine is significant in the realm of halogen chemistry, as halogens often enhance reactivity and influence the biological behavior of organic compounds.
  • Synthesis Journey: The synthesis of such derivatives often involves multi-step reactions, making it a challenging yet rewarding endeavor for chemistry students and researchers looking to expand their expertise in organic synthesis.

Moreover, its role in various chemical assays and potential to serve as a lead compound for further drug development exemplifies the incredible journey that compounds like 2-(3-acetamido-2,4,6-triiodo-phenyl)acetic acid can undergo in the realms of both academic research and industrial applications.

ADVERTISEMENT